{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:47:51Z","timestamp":1793976471356,"version":"4.8.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000215.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000}}],"reference-count":64,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000215.pub5","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T22:27:13Z","timestamp":1622586433000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Anthelmintics for people with neurocysticercosis"],"prefix":"10.1002","volume":"2021","author":[{"given":"Edward JM","family":"Monk","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Abba","sequence":"additional","affiliation":[{"name":"Department of Primary Care and Mental Health; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi N","family":"Ranganathan","sequence":"additional","affiliation":[{"name":"Institute of Neurology; Madras Medical College; Chennai India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"10.1002\/14651858.CD000215.pub5-BIB0001|cit1","first-page":"1","article-title":"Short course of albendazole therapy for neurocysticercosis: a prospective randomized trial comparing three days, eight days and the control group without albendazole","volume":"10","author":"Alarcon","year":"2001","journal-title":"Revista Ecuatoriana de Neurologia"},{"issue":"8","key":"10.1002\/14651858.CD000215.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00006454-199808000-00007","article-title":"Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo controlled, double-blind trial","volume":"17","author":"Baranwal","year":"1998","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/tropej\/48.4.219","article-title":"Morphometry of single small enhancing computed tomographic lesions: outcome and effect of albendazole therapy","volume":"48","author":"Baranwal","year":"2002","journal-title":"Journal of Tropical Pediatrics"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2310\/7010.2001.7057","article-title":"Seizure recurrence and single small enhancing computed tomographic lesions: prognostic factors on long-term follow-up","volume":"6","author":"Baranwal","year":"2001","journal-title":"Journal of Child Neurology"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/epi.16302","article-title":"Exploring the complex associations over time among albendazole treatment, cyst evolution, and seizure outcomes in neurocysticercosis","volume":"60(9)","author":"Carpio","year":"2019","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/jnnp.2008.144899","article-title":"Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial","volume":"79","author":"Carpio","year":"2008","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/trstmh\/trz073","article-title":"A longitudinal analysis of albendazole treatment effect on neurocysticercosis cyst evolution using multistate models","volume":"1;113(12)","author":"Montgomery","year":"2019","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"11","key":"10.1002\/14651858.CD000215.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/trstmh\/trv078","article-title":"The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis","volume":"109","author":"Romo","year":"2015","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/trstmh\/try023","article-title":"The effect of albendazole treatment on non-seizure outcomes in patients with symptomatic neurocysticercosis","volume":"1;112(2)","author":"Thapa","year":"2018","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0010|cit10","first-page":"517","article-title":"Three day albendazole therapy in patients with a solitary cysticercus granuloma: a randomized double blind placebo controlled study","volume":"41(3)","author":"Chaurasia","year":"2010","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"12","key":"10.1002\/14651858.CD000215.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jocn.2006.09.004","article-title":"Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study","volume":"14","author":"Das","year":"2007","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jns.2009.09.018","article-title":"Natural history of solitary cerebral cysticercosis on serial magnetic resonance imaging and the effect of albendazole therapy on its evolution","volume":"288(1-2)","author":"Souza","year":"2010","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/j.1528-1167.2011.03189.x","article-title":"Perilesional gliosis around solitary cerebral parenchymal cysticerci and long-term seizure outcome: a prospective study using serial magnetization transfer imaging","volume":"52(10)","author":"Souza","year":"2011","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/197140091002300506","article-title":"Prospective quantitative imaging study by magnetisation transfer for appearance of perilesional gliosis in solitary cerebral cysticercal lesion","volume":"23(5)","author":"Souza","year":"2010","journal-title":"Neuroradiology Journal"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jns.2008.09.010","article-title":"Randomized controlled trial of albendazole in new onset epilepsy and MRI confirmed solitary cerebral cysticercal lesion: effect on long-term seizure outcome","volume":"276","author":"Souza","year":"2009","journal-title":"Journal of the Neurological Sciences"},{"issue":"2","key":"10.1002\/14651858.CD000215.pub5-BIB0016|cit16","first-page":"6 [ePages]","article-title":"Clinical trial of praziquantel and prednisone in rural patients with neurocysticercosis presenting with recurrent epileptic attacks","volume":"1","author":"Foyaca-Sibat","year":"2001","journal-title":"Internet Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD000215.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa031294","article-title":"A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis","volume":"350","author":"Garcia","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000215.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0035-9203(03)90075-7","article-title":"Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo controlled trial in newly diagnosed cases","volume":"97","author":"Gogia","year":"2003","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD000215.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3476(03)00211-7","article-title":"Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomised controlled trial","volume":"143","author":"Kalra","year":"2003","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"36-41","DOI":"10.1016\/j.jns.2012.02.006","article-title":"Three-day versus 15-day course of albendazole therapy in solitary cysticercus granuloma: an open label randomized trial","volume":"316","author":"Khurana","year":"2012","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.44.7.1344","article-title":"Albendazole in single CT ring lesions in epilepsy","volume":"44","author":"Padma","year":"1994","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD000215.pub5-BIB0022|cit22","first-page":"255","article-title":"Albendazole in neurocysticercosis","volume":"8","author":"Padma","year":"1995","journal-title":"National Medical Journal of India"},{"issue":"4","key":"10.1002\/14651858.CD000215.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/088307380001500401","article-title":"Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy","volume":"15","author":"Singhi","year":"2000","journal-title":"Journal of Child Neurology"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/088307380401900503","article-title":"Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis","volume":"19(5)","author":"Singhi","year":"2004","journal-title":"Journal of Child Neurology"},{"issue":"5","key":"10.1002\/14651858.CD000215.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archneur.1988.00520290064015","article-title":"Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial","volume":"45","author":"Sotelo","year":"1988","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archneur.1989.00520470099034","article-title":"Neurocysticercosis: short course of treatment with albendazole","volume":"46(11)","author":"Alarcon","year":"1989","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD000215.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/0035-9203(93)90095-8","article-title":"Short course albendazole treatment for neurocysticercosis in Columbia","volume":"87","author":"Botero","year":"1993","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.clineuro.2004.12.013","article-title":"Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst","volume":"108(2)","author":"Bustos","year":"2006","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1001\/archinte.1995.00430180088010","article-title":"Is the course of neurocysticercosis modified by treatment with antihelminthic agents?","volume":"155(18)","author":"Carpio","year":"1995","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0030|cit30","first-page":"561","article-title":"Effect of praziquantel in the treatment of 111 cases of cerebral cysticercosis cellulosae","volume":"23(9)","author":"Chen","year":"1984","journal-title":"Zhonghua Nei Ke Za Zhi [Chinese Journal of Internal Medicine]"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0031|cit31","first-page":"152-4","article-title":"Neurocysticercosis: optimal dose treatment with albendazole","volume":"133(1-2)","author":"Cruz","year":"1995","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0032|cit32","first-page":"659-61","article-title":"Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients","volume":"62(6)","author":"Del Brutto","year":"1997","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0033|cit33","first-page":"1079-81","article-title":"Single-day praziquantel versus 1-week albendazole for neurocysticercosis","volume":"23(52)","author":"Del Brutto","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archinte.1987.00370040120021","article-title":"Albendazole therapy for neurocysticercosis","volume":"147(4)","author":"Escobedo","year":"1987","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0035|cit35","first-page":"226-33","article-title":"Clinical trial of praziquantel and prednisone in HIV-patients presenting uncontrolled epilepsy due to intraparenchymal neurocysticercosis","volume":"57 Suppl 2","author":"Foyaca-Sibat","year":"2016","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"486-9","DOI":"10.1093\/infdis\/175.2.486","article-title":"Serologic evolution of neurocysticercosis patients after antiparasitic therapy","volume":"175","author":"Garcia","year":"1997","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD000215.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1421-7","DOI":"10.1212\/WNL.48.5.1421","article-title":"Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment","volume":"48","author":"Garcia","year":"1997","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0038|cit38","first-page":"436-8","article-title":"Albendazole trials at 15 or 30 mg\/kg\/day for subarachnoid and intraventricular cysticercosis","volume":"66(3)","author":"Gongora-Rivera","year":"2996","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0039|cit39","first-page":"403-6","article-title":"Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis","volume":"28(5)","author":"Kaur","year":"2009","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0040|cit40","first-page":"79","article-title":"A clinical study on the treatment of cerebral cysticercosis with praziquantel","volume":"64(2)","author":"Ma","year":"1984","journal-title":"Zhonghua Yi Xue Za Zhi [Chinese Journal of Internal Medicine]"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0303-8467(00)00110-4","article-title":"Short regimen of praziquantel in the treatment of single brain enhancing lesions","volume":"102(4)","author":"Pretell","year":"2000","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"3","key":"10.1002\/14651858.CD000215.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"268-72","DOI":"10.1097\/01.inf.0000055095.84136.a2","article-title":"One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo controlled double-blind trial","volume":"22","author":"Singhi","year":"2003","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"69-72","DOI":"10.1007\/BF00314663","article-title":"Comparison of therapeutic regimen of anticystercal drugs for parenchymal brain cysticercosis","volume":"237","author":"Sotelo","year":"1990","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jnnp.2007.128058","article-title":"Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy","volume":"79(3)","author":"Thussu","year":"2008","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0045|cit45","unstructured":"Boutron I Page MJ Higgins JPT Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"issue":"5","key":"10.1002\/14651858.CD000215.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"e1152","DOI":"10.1371\/journal.pntd.0001152","article-title":"Clinical manifestations associated with neurocysticercosis: a systematic review","volume":"5","author":"Carabin","year":"2011","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"5","key":"10.1002\/14651858.CD000215.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"e1500","DOI":"10.1371\/journal.pntd.0001500","article-title":"Neurocysticercosis: neglected but not forgotten","volume":"6","author":"Coyle","year":"2012","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0048|cit48","first-page":"e2","article-title":"Deaths associated with cysticercosis. Report of three cases and review of the literature","volume":"12(6)","author":"Degiorgio","year":"2002","journal-title":"Neurosurgical Focus"},{"issue":"3","key":"10.1002\/14651858.CD000215.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1535-7597.2004.43008.x","article-title":"Neurocysticercosis","volume":"4","author":"Degiorgio","year":"2004","journal-title":"Epilepsy Currents"},{"issue":"1","key":"10.1002\/14651858.CD000215.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7326\/0003-4819-145-1-200607040-00009","article-title":"Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel","volume":"145","author":"Del Brutto","year":"2006","journal-title":"Annals of Internal Medicine"},{"issue":"372","key":"10.1002\/14651858.CD000215.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jns.2016.11.045","article-title":"Revised diagnostic criteria for neurocysticercosis","volume":"15","author":"Del Brutto","year":"2017","journal-title":"Journal of Neurological Science"},{"issue":"4","key":"10.1002\/14651858.CD000215.pub5-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.15.4.747-756.2002","article-title":"Current consensus guidelines for treatment of neurocysticercosis","volume":"15","author":"Garcia","year":"2002","journal-title":"Clinical Microbiology Reviews"},{"issue":"7303","key":"10.1002\/14651858.CD000215.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD000215.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/WNL.55.10.1485","article-title":"Calcified neurocysticercosis lesions and postsurgery seizure control in temporal lobe epilepsy","volume":"55","author":"Leite","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1371\/journal.pntd.0000371","article-title":"Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures","volume":"3","author":"Lescano","year":"2009","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000215.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/0883073807300295","article-title":"Does albendazole affect seizure remission and computed tomography response in children with neurocysticercosis? A systematic review and meta-analysis","volume":"22","author":"Mazumdar","year":"2007","journal-title":"Journal of Child Neurology"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0057|cit57","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2020"},{"issue":"3","key":"10.1002\/14651858.CD000215.pub5-BIB0058|cit58","first-page":"399","article-title":"A proposal to declare neurocysticercosis an international reportable disease","volume":"78","author":"Roman","year":"2000","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0059|cit59","unstructured":"Ryan R Hill S How to GRADE the quality of the evidence version 3.0. Cochrane Consumers and Communication Group. Cochrane 2016 Available at cccrg.cochrane.org\/author-resources"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0060|cit60","volume-title":"First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases","volume":"1","author":"Savioli","year":"2010"},{"key":"10.1002\/14651858.CD000215.pub5-BIB0061|cit61","unstructured":"Sch\u00fcnemann HJ Higgins JPT Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"issue":"8","key":"10.1002\/14651858.CD000215.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"e49-75","DOI":"10.1093\/cid\/ciy157","article-title":"Diagnosis and treatment of neurocysticercosis: 2017. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"66","author":"White","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000215.pub5-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000215.pub3","article-title":"Anthelmintics for people with neurocysticercosis","author":"Abba","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000215.pub5-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000215.pub2","article-title":"Drugs for treating neurocysticercosis (tapeworm infection of the brain)","author":"Salinas","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T09:52:17Z","timestamp":1667901137000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000215.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000215.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}